Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation - Takeaways - MDSpire

Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation

  • By

  • Baptiste Lemaire

  • Christophe Combescure

  • Yves Chalandon

  • Nicolas Vuilleumier

  • Sophie Waldvogel Abramowski

  • June 25, 2022

  • 0 min

Share

  • 1

    ABO-incompatible HSCT can lead to hemolysis and complications like pure red cell aplasia, impacting transfusion needs.

  • 2

    The study investigates the kinetics of isoagglutinins A and B in patients post-ABO-incompatible HSCT over one year.

  • 3

    Myeloablative conditioning regimens may enhance the disappearance of isoagglutinins compared to reduced intensity protocols.

  • 4

    Isoagglutinin presence and titer correlate with post-transplant immunohematological complications and potential relapse.

  • 5

    Statistical analyses of isoagglutinin events utilized non-parametric survival methods to assess disappearance and appearance rates.

Original Source(s)

Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation

  • by Baptiste Lemaire, Christophe Combescure, Yves Chalandon, Nicolas Vuilleumier, Sophie Waldvogel Abramowski

  • June 25, 2022

Related Content

Temporal variation in nutritional status and preoperative anemia among patients with retroperitoneal soft tissue sarcoma: a retrospective longitudinal cohort study

Clinical Reasoning in Practice: Implementing High-Value Care When Data Discrepancies Arise

Patient Resource on Vascular Disorders: Understanding Hereditary Hemorrhagic Telangiectasia (HHT)